These results suggested that decreased levels of TGM2, PYGB, and S100A6 sensitized radioresistant ESCC cells to IR treatment and may play a crucial role in the development of acquired radioresistance. The gene discussed is S100A6; the disease is esophageal squamous cell carcinoma.